16-1218596-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_021098.3(CACNA1H):​c.5832C>T​(p.His1944His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000265 in 1,564,796 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00025 ( 5 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.265

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 16-1218596-C-T is Benign according to our data. Variant chr16-1218596-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 529685.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.265 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000368 (56/152202) while in subpopulation AMR AF = 0.0019 (29/15292). AF 95% confidence interval is 0.00136. There are 0 homozygotes in GnomAd4. There are 34 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 56 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5832C>T p.His1944His synonymous_variant Exon 33 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5832C>T p.His1944His synonymous_variant Exon 33 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.5847C>T p.His1949His synonymous_variant Exon 32 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.5850C>T p.His1950His synonymous_variant Exon 32 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5814C>T p.His1938His synonymous_variant Exon 32 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.5847C>T p.His1949His synonymous_variant Exon 33 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5832C>T p.His1944His synonymous_variant Exon 33 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.5793C>T p.His1931His synonymous_variant Exon 33 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.5814C>T p.His1938His synonymous_variant Exon 32 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.5775C>T p.His1925His synonymous_variant Exon 32 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5832C>T p.His1944His synonymous_variant Exon 33 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5814C>T p.His1938His synonymous_variant Exon 32 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5832C>T p.His1944His synonymous_variant Exon 33 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5832C>T p.His1944His synonymous_variant Exon 33 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5832C>T p.His1944His synonymous_variant Exon 33 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5832C>T non_coding_transcript_exon_variant Exon 33 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1784C>T non_coding_transcript_exon_variant Exon 32 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.*913C>T non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*3683C>T non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*5276C>T non_coding_transcript_exon_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*806C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*691C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1444C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*499C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*499C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5814C>T non_coding_transcript_exon_variant Exon 32 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5832C>T non_coding_transcript_exon_variant Exon 33 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5832C>T non_coding_transcript_exon_variant Exon 33 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*948C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1784C>T 3_prime_UTR_variant Exon 32 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.*913C>T 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*3683C>T 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*5276C>T 3_prime_UTR_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*806C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*691C>T 3_prime_UTR_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1444C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*499C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*499C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*948C>T 3_prime_UTR_variant Exon 33 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.000368
AC:
56
AN:
152084
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000673
AC:
117
AN:
173942
AF XY:
0.000674
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00109
Gnomad ASJ exome
AF:
0.00323
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000391
Gnomad OTH exome
AF:
0.00298
GnomAD4 exome
AF:
0.000254
AC:
359
AN:
1412594
Hom.:
5
Cov.:
38
AF XY:
0.000276
AC XY:
193
AN XY:
698046
show subpopulations
African (AFR)
AF:
0.0000308
AC:
1
AN:
32450
American (AMR)
AF:
0.000771
AC:
29
AN:
37592
Ashkenazi Jewish (ASJ)
AF:
0.00312
AC:
79
AN:
25296
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37148
South Asian (SAS)
AF:
0.000548
AC:
44
AN:
80264
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48758
Middle Eastern (MID)
AF:
0.00649
AC:
37
AN:
5698
European-Non Finnish (NFE)
AF:
0.000121
AC:
132
AN:
1086834
Other (OTH)
AF:
0.000632
AC:
37
AN:
58554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000368
AC:
56
AN:
152202
Hom.:
0
Cov.:
30
AF XY:
0.000457
AC XY:
34
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41512
American (AMR)
AF:
0.00190
AC:
29
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68002
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000737
Hom.:
2
Bravo
AF:
0.000450
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CACNA1H-related disorder Benign:1
Apr 03, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 16, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.17
DANN
Benign
0.62
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372529098; hg19: chr16-1268596; COSMIC: COSV52355769; COSMIC: COSV52355769; API